Raymakers, A. J. N., Van de Wiele, V. L., Kesselheim, A. S., & Tu, S. S. (2025). Changes In Biologic Drug Revenues After Administrative Patent Challenges. Health Affairs, 44(3), 274. https://doi.org/10.1377/hlthaff.2024.00504
Chicago Style (17th ed.) CitationRaymakers, Adam J. N., Victor L. Van de Wiele, Aaron S. Kesselheim, and S. Sean Tu. "Changes In Biologic Drug Revenues After Administrative Patent Challenges." Health Affairs 44, no. 3 (2025): 274. https://doi.org/10.1377/hlthaff.2024.00504.
MLA (9th ed.) CitationRaymakers, Adam J. N., et al. "Changes In Biologic Drug Revenues After Administrative Patent Challenges." Health Affairs, vol. 44, no. 3, 2025, p. 274, https://doi.org/10.1377/hlthaff.2024.00504.
Warning: These citations may not always be 100% accurate.